Persistent Reversal of Enhanced Amphetamine Intake by Transient CaMKII Inhibition
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Amphetamine exposure transiently increases Ca 2+/calmodulin-dependent protein kinase II (CaMKII) α expression in the nucleus accumbens (NAcc) shell and this persistently increases local GluA1 S831 phosphorylation and enhances behavioral responding to the drug. Here we assessed whether transiently interfering with CaMKII signaling using a dominant-negative CaMKIIα mutant delivered to the NAcc shell with herpes simplex viral vectors could reverse these long-lasting biochemical and behavioral effects observed following exposure to amphetamine. As expected, transient expression of CaMKIIα K42M in the NAcc shell produced a corresponding transient increase in CaMKIIα and decrease in pCaMKIIα (T286) protein levels in this site. Remarkably, this transient inhibition of CaMKII activity produced a long-lasting reversal of the increased GluA1 S831 phosphorylation levels in NAcc shell and persistently blocked the enhanced locomotor response to and self-administration of amphetamine normally observed in rats previously exposed to the drug. Together, these results indicate that even transient interference with CaMKII signaling may confer long-lasting benefits in drug-sensitized individuals and point to CaMKII and its downstream pathways as attractive therapeutic targets for the treatment of stimulant addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of CaMKII action in long-term potentiation
Lisman, J., Yasuda, R., & Raghavachari, S. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3192 · Cited by 1,134
Derkach, V., Barria, A., & Soderling, T. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3269 · Cited by 842 · cited 13×
“Remarkably, this transient inhibition of CaMKII activity produced a long-lasting reversal of the increased GluA1 S831 phosphorylation levels in NAcc shell and persistently blocked the enhanced locomotor response to and self-administration of amphetamine normally observed in rats previously exposed to the drug.”
BackgroundInfluentialInteraction with the NMDA receptor locks CaMKII in an active conformation
Bayer, K.-U., De Koninck, P., Leonard, A. S., Hell, J. W., & Schulman, H. (2001) · Nature · doi:10.1038/35081080 · Cited by 732 · cited 2×
“…interferes with the targeting of holoenzymes to the NMDA-type glutamate receptor subunit GluN2 (Bayer et al., 2006; O’Leary et al., 2011), which is regulated by nucleotide binding to CaMKII (O’Leary et al., 2011) and also generates autonomous activity (Bayer et al., 2001; Bayer et al., 2006).”
BackgroundSelf-citationNMDA Receptor Subunit Composition Controls Synaptic Plasticity by Regulating Binding to CaMKII
Barria, A., & Malinow, R. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.034 · Cited by 709 · cited 1×
“As normal LTP and LTP-induced GluA1 S831 phosphorylation require NMDA receptor-bound CaMKII (Barria and Malinow, 2005; Halt et al., 2012) and the CaMKII K42M mutation disrupts this binding (O’Leary et al., 2011), we examined the GluA1 S831 phosphorylation state in our animals.”
BackgroundKühl, M., Sheldahl, L. C., Malbon, C. C., & Moon, R. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12701 · Cited by 517
Vezina, P. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.001 · Cited by 515
Self-citationCaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking
Anderson, S. M., Famous, K. R., Sadri-Vakili, G., Kumaresan, V., Schmidt, H. D., Bass, C. E., Terwilliger, E. F., Cha, J.-H. J., & Pierce, R. C. (2008) · Nature Neuroscience · doi:10.1038/nn2054 · Cited by 295 · cited 6×
“Conversely, NAcc shell infusion of a CaMKII inhibitor (KN93) prevents cocaine-induced reinstatement of drug seeking (Anderson et al., 2008), as well as the expression of enhanced NAcc dopamine overflow (Pierce and Kalivas, 1997), cocaine-induced locomotion (Pierce et al.”
BackgroundInfluentialMechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating
Kristensen, A. S., Jenkins, M. A., Banke, T. G., Schousboe, A., Makino, Y., Johnson, R. C., Huganir, R., & Traynelis, S. F. (2011) · Nature Neuroscience · doi:10.1038/nn.2804 · Cited by 286 · cited 1×
“CaMKII mediates LTP by increasing both the number and the conductance of synaptic AMPA-type glutamate receptors (Coultrap and Bayer, 2012), the latter by phosphorylating their GluA1 subunit at S831 (Derkach et al., 1999; Kristensen et al., 2011).”
BackgroundLee, H.-K., Takamiya, K., He, K., Song, L., & Huganir, R. L. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00835.2009 · Cited by 261 · cited 1×
“While GluA1 S831A mutant mice do not show impairments in hippocampal LTP or LTD (Lee et al., 2010), they do show deficits in responding for a conditioned reinforcer (Crombag et al., 2008).”
BackgroundRole of the CaMKII/NMDA Receptor Complex in the Maintenance of Synaptic Strength
Sanhueza, M., Fernandez-Villalobos, G., Stein, I. S., Kasumova, G., Zhang, P., Bayer, K. U., Otmakhov, N., Hell, J. W., & Lisman, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1250-11.2011 · Cited by 248
Self-citation
Cited by
CaM Kinase: Still Inspiring at 40
Bayer, K. U., & Schulman, H. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.033 · Cited by 326
Self-citationThe CaMKII/NMDAR complex as a molecular memory
Sanhueza, M., & Lisman, J. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-10 · Cited by 166
Striatal ups and downs: Their roles in vulnerability to addictions in humans
Leyton, M., & Vezina, P. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.018 · Cited by 165
“…target enhanced responding to the drug and its control by drug associated stimuli (Kim et al., 2005; Barrett et al., 2008; Venugopalan et al., 2011; Loweth et al., 2013) or that retrain the patient to orient toward other cues and rewards, as is achieved in attentional bias training (Attwood et…”
Self-citationMemory Erasure Experiments Indicate a Critical Role of CaMKII in Memory Storage
Rossetti, T., Banerjee, S., Kim, C., Leubner, M., Lamar, C., Gupta, P., Lee, B., Neve, R., & Lisman, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.010 · Cited by 94
Self-citationAutonomous CaMKII requires further stimulation by Ca 2+ /calmodulin for enhancing synaptic strength
Barcomb, K., Buard, I., Coultrap, S. J., Kulbe, J. R., O'Leary, H., Benke, T. A., & Bayer, K. U. (2014) · The FASEB Journal · doi:10.1096/fj.14-250407 · Cited by 52
“to disrupt endogenous CaMKII signaling (41), they also”
BackgroundSelf-citation
Metadata
- Authors
- Loweth, J. A., Li, D., Cortright, J. J., Wilke, G., Jeyifous, O., Neve, R. L., Bayer, K. U., & Vezina, P.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2013-01-23
- Volume
- 33
- Issue
- 4
- Pages
- 1411-1416
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2015945228
- Cited by
- 43
- References
- 13
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Persistent Reversal of Enhanced Amphetamine Intake by Transient CaMKII Inhibition. https://app.cochat.ai/papers/10.1523/jneurosci.4386-13.2013
- The paper
- Loweth, J. A., Li, D., Cortright, J. J., Wilke, G., Jeyifous, O., Neve, R. L., Bayer, K. U., & Vezina, P. (2013). Persistent Reversal of Enhanced Amphetamine Intake by Transient CaMKII Inhibition. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.4386-13.2013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.